20 Recruiting Advanced Solid Tumor Clinical Trials in Arizona
Explore active advanced solid tumor research studies enrolling across Arizona. Verify eligibility and contact site coordinators.
📍 Find Near Me by DistanceBrowse by City
Recruiting Advanced Solid Tumor Studies in Arizona
First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors
📍 Site 139 — Bullhead City, Arizona
View Study & Checklist ➔A Phase 1/2a Study of IMM-1-104 in Participants With Advanced or Metastatic Solid Tumors
📍 Mayo Clinic — Scottsdale, Arizona
View Study & Checklist ➔A Phase 1 Clinical Study of NXP900 in Subjects With Advanced Cancers
📍 Mayo Clinic — Phoenix, Arizona
View Study & Checklist ➔Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
📍 Investigative Site #132 — Phoenix, Arizona
View Study & Checklist ➔Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers
📍 University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔A Study to Evaluate PEEL-224 in Patients With Advanced Solid Tumors
📍 HonorHealth Research Institiute — Scottsdale, Arizona
View Study & Checklist ➔Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors
📍 Investigative Site #108 — Goodyear, Arizona
View Study & Checklist ➔A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Phase 1, First in Human Study of TORL-4-500 in Patients With Advanced Cancer
📍 Mayo Clinic Phoenix — Phoenix, Arizona
View Study & Checklist ➔SW-682 in Advanced Solid Tumors
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)
📍 Mayo Clinic in Arizona — Scottsdale, Arizona
View Study & Checklist ➔FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔Phase 1/2 Study of Intravenous Injection of STX-003 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
📍 HonorHealth Research Institute — Scottsdale, Arizona
View Study & Checklist ➔A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔Study of SGN1 in Patients With Advanced Solid Tumor
📍 Banner MD Anderson Cancer Center — Gilbert, Arizona
View Study & Checklist ➔A First-in-Human Study of YL217 in Patients With Advanced Solid Tumors
📍 Mayo Clinic Arizona — Phoenix, Arizona
View Study & Checklist ➔Phase 1/2 Study of Intratumoral Injection of STX-001 in Advanced Solid Tumors as Monotherapy or in Combination With Pembrolizumab
📍 HonorHealth Research and Innovation Institute — Scottsdale, Arizona
View Study & Checklist ➔A Study of KK2269 in Adult Participants With Solid Tumors
📍 Mayo Clinic Arizona — Scottsdale, Arizona
View Study & Checklist ➔Phase 1 Study of Intratumoral Administration of VAX014 With Expansion in Combination With a Checkpoint Inhibitor in Subjects With Advanced Solid Tumors
📍 University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors
📍 The University of Arizona Cancer Center — Tucson, Arizona
View Study & Checklist ➔